Skip to main content
. 2023 Oct 5;6:100122. doi: 10.1016/j.gloepi.2023.100122

Table 2.

Results of stratified analysis of the thyroid cancer risk estimates according to the oophorectomy condition.


Combined risk estimate
Test of heterogeneity
Publication bias
N.b Value (95% CI) p Q I2% p p (Egger test) p (Begg test)
Any hysterectomy 13 1.64 (1.48–1.81) <0.0001 16.83 28.68 0.156 0.382 0.542
Self-reported 11 1.62 (1.43–1.84) <0.0001 16.05 37.69 0.098 0.477 0.697
Hospital record 2 1.67 (1.43–1.96) <0.0001 0.76 0.00 0.384
Case-control 4 1.57 (1.25–1.97) <0.0001 0.88 0.00 0.829 0.268 0.497
Cohort 9 1.64 (1.45–1.86) <0.0001 15.69 49.01 0.047 0.313 0.404
Hysterectomy without oophorectomy 8 1.59 (1.43–1.77) <0.0001 10.19 31.32 0.178 0.585 0.621
Self-reported 6 1.65 (1.40–1.95) <0.0001 4.41 0.00 0.492 0.648 0.573
Hospital record 2 1.54 (1.27–1.87) <0.0001 5.76 82.64 0.016
Case-control 4 1.61 (1.23–2.11) 0.001 2.35 0.00 0.504 0.692 0.497
Cohort 4 1.59 (1.38–1.82) <0.0001 7.83 61.71 0.050 0.694 1.000
Age at surgery <45 y 7 1.81 (1.51–2.17) <0.0001 6.45 6.93 0.375 0.689 0.652
Age at surgery >45 y 7 1.38 (1.13–1.69) 0.002 13.07 54.1 0.042 0.598 0.453
Hysterectomy with oophorectomy 14 1.39 (1.16–1.67) <0.0001 22.45 42.1 0.049 0.785 0.352
Case-control 6 1.44 (1.04–1.99) 0.026 3.39 0.00 0.64 0.097 0.015
Cohort 8 1.34 (1.06–1.70) 0.013 19.06 63.27 0.008 0.161 0.216
Hysterectomy-BSOc 10 1.46 (1.19–1.77) <0.0001 17.98 49.94 0.035 0.942 0.531
Case-control 4 1.41 (1.00–1.98) 0.051 3.03 1.12 0.386 0.212 0.042
Cohort 6 1.45 (1.14–1.85) 0.003 14.83 66.28 0.011 0.501 0.573
Hysterectomy-USOd 4 0.99 (0.62–1.57) 0.967 1.76 0.00 0.623 0.069 0.174
Case-control 2 1.92 (0.64–5.79) 0.247 0.08 0.00 0.780
Cohort 2 0.86 (0.52–1.43) 0.561 0.01 0.00 0.914

aThe risk estimates were calculated using the random-effects model; bNumber of data used to calculate the risk; cBilateral Salpingo Oophorectomy; dUnilateral Salpingo Oophorectomy.